Description
Acute graft-versus-host disease: diagnosis, pathophysiology and prevention
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Acute graft-versus-host disease: diagnosis, pathophysiology and prevention
€3.03
Related products
-
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart
